DigiPharmaX Awards 2024 Celebrating Pharma Excellence
(This story has not been edited by THE WEEK and is auto-generated from a PTI
Stay updated with breaking news from Globalspace Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(This story has not been edited by THE WEEK and is auto-generated from a PTI
Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra)/ Hyderabad (Telangana) [India], January 9: GlobalSpace Technologies Limited unveiled GoRoga, India's first Anti-Stress wearable under the Make in India initiative. The inaugural event, held at Chancellor Hall, NSCI Club, Worli, Mumbai on 4th January 2024 was jointly presided by Krishna Singh, Founder and CEO, GlobalSpace Technologies and Ami Lebendiker, Co-Founder and CEO, RogaLife, USA. A trailblazer in digital pharma and healthcare for over a decade, GlobalSpace Technologies are pioneers in digital pharma...
Dividend stocks: Asian Paints, NTPC, RailTel Corporation, Route Mobile, and Symphony stocks are trading ex-dividend today. Globalspace Technologies will launch Rights Issue
GlobalSpace Technologies announces alliance with Pfizer Limited for Vaccine awareness and teleconsultation on DocExa Platform Posted On: 2021-02-17 22:21:35 (Time Zone: Arizona, USA) GlobalSpace Technologies Limited is delighted to announce its strategic partnership with Pfizer, a leading pharmaceutical company for integrating downstream function of providing further valueadded service in the field of Doctor e-consultation facilitation Tab. Under this agreement, GlobalSpace group would leverage its Makebot platform for vaccine awareness and DocExa platform for consultation by specialists...
GlobalSpace Technologies Limited announces Q3FY21 results Posted On: 2021-02-11 22:46:36 (Time Zone: Arizona, USA) GlobalSpace Technologies Limited (BSE Code: 540654), one of the leading HealthTech and EduTech digital platform provider, has announced results for the third quarter ended on December 31, 2020. Quarterly Comparisons: - PAT: INR 18.62 Mn (against loss of INR 32.89 Mn in Q3FY2020) - Revenues: INR 67.61 Mn (grew by 12.87% on y-o-y basis) - EBITDA: INR 29.74 Mn (against loss of INR 31.13 Mn in Q3FY2020) - EBITDA and PAT margins stood at 43.98% and 27.54% respectively. - There ha...